Green synthesis of silver nanoparticles for the targeted delivery to HER2-overexpressing cancer cells

被引：0
|
作者：
Shipunova, V. [1 ,2 ]
Belova, M. [3 ]
Komedchikova, E. [1 ]
Babenyshev, A. [4 ]
Deyev, S. [1 ,2 ]
机构：
[1] RAS, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
[2] Natl Res Nucl Univ MEPhI, Moscow, Russia
[3] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Moscow, Russia
[4] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia
来源：
FEBS OPEN BIO | 2019年 / 9卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-36-035
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [21] HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer
    Pereira, Patricia M. R.
    Ragupathi, Ashwin
    Shmuel, Shayla
    Mandleywala, Komal
    Viola, Nerissa T.
    Lewis, Jason S.
    MOLECULAR PHARMACEUTICS, 2020, 17 (01) : 327 - 337
  • [22] Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2-Overexpressing Metastatic Breast Cancer
    Huang, Yuan
    Fu, Peifen
    Fan, Weimin
    CURRENT DRUG TARGETS, 2013, 14 (08) : 889 - 898
  • [23] New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available
    Abramson, Vandana
    Arteaga, Carlos L.
    CLINICAL CANCER RESEARCH, 2011, 17 (05) : 952 - 958
  • [24] DARPin_9-29-Targeted Mini Gold Nanorods Specifically Eliminate HER2-Overexpressing Cancer Cells
    Proshkina, Galina
    Deyev, Sergey
    Ryabova, Anastasiya
    Tayanti, Francesco
    Menziani, Maria Cristina
    Cohen, Roy
    Katrivas, Liat
    Kotlyar, Alexander
    ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (38) : 34645 - 34651
  • [25] Activity of fulvestrant in HER2-overexpressing advanced breast cancer
    Robertson, J. F. R.
    Steger, G. G.
    Neven, P.
    Barni, S.
    Gieseking, F.
    Nole, F.
    Pritchard, K. I.
    O'Malley, F. P.
    Simon, S. D.
    Kaufman, B.
    Petruzelka, L.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1246 - 1253
  • [26] Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells
    Shattuck, David L.
    Miller, Jamie K.
    Carraway, Kermit L., III
    Sweeney, Colleen
    CANCER RESEARCH, 2008, 68 (05) : 1471 - 1477
  • [27] Effects of trastuzumab and paclitaxel in HER2-overexpressing breast cancer
    Li, Songhua
    Higuchi, Hideo
    Ohuchi, Noriaki
    FUTURE MEDICAL ENGINEERING BASED ON BIONANOTECHNOLOGY, PROCEEDINGS, 2006, : 395 - +
  • [28] Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells
    Minh Truong Do
    Kim, Hyung Gyun
    Choi, Jae Ho
    Khanal, Tilak
    Park, Bong Hwan
    Thu Phuong Tran
    Jeong, Tae Cheon
    Jeong, Hye Gwang
    FOOD CHEMISTRY, 2013, 141 (03) : 2591 - 2599
  • [29] Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
    Zhang, Peng
    Chen, Yiying
    Gong, Miaomiao
    Zhuang, Zhumei
    Wang, Yueyue
    Mu, Lin
    Wang, Tianjiao
    Pan, Jinjin
    Liu, Yanan
    Xu, Jianming
    Liang, Rui
    Yuan, Yuhui
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (01) : 52 - 65
  • [30] Target Therapy in HER2-Overexpressing Breast Cancer Patients
    Amodio, Rosalba
    Zarcone, Maurizio
    Cusimano, Rosanna
    Campisi, Ildegarda
    Dolcemascolo, Cecilia
    Traina, Adele
    Agostara, Biagio
    Romano, Nino
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2011, 15 (06) : 363 - 367
12345